Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer
- 1 March 1985
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 20 (3) , 290-297
- https://doi.org/10.1016/0090-8258(85)90210-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)American Journal of Obstetrics and Gynecology, 1983
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- cis-Platinum (II) DiamminedichloridePublished by Springer Nature ,1974
- Chemotherapy in the treatment of cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1970
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958